The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease

Abstract Background There is growing interest in identifying sensitive composite cognitive tests to serve as primary endpoints in preclinical Alzheimer’s disease (AD) treatment trials. We reported previously a composite cognitive test score sensitive to tracking preclinical AD decline up to 5 years...

Descrición completa

Detalles Bibliográficos

Principais autores:	Jessica B. Langbaum, Noel N. Ellison, Angelika Caputo, Ronald G. Thomas, Carolyn Langlois, Marie-Emmanuelle Riviere, Ana Graf, Cristina Lopez Lopez, Eric M. Reiman, Pierre N. Tariot, Suzanne B. Hendrix
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2020-05-01
Series:	Alzheimer’s Research & Therapy
Assuntos:	Preclinical Alzheimer’s disease Cognition Composite cognitive endpoint Clinical trials
Acceso en liña:	http://link.springer.com/article/10.1186/s13195-020-00633-2
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!